GIORDANO, Giulia Maria
 Distribuzione geografica
Continente #
EU - Europa 5.503
AS - Asia 2.730
NA - Nord America 2.182
SA - Sud America 398
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 10.847
Nazione #
RU - Federazione Russa 4.010
US - Stati Uniti d'America 2.133
SG - Singapore 943
CN - Cina 512
IE - Irlanda 480
IT - Italia 469
HK - Hong Kong 459
BR - Brasile 333
VN - Vietnam 290
KR - Corea 173
GB - Regno Unito 127
DE - Germania 113
JP - Giappone 111
IN - India 84
FR - Francia 65
TR - Turchia 63
UA - Ucraina 44
GR - Grecia 41
FI - Finlandia 37
BD - Bangladesh 26
SE - Svezia 24
AT - Austria 21
MX - Messico 21
AR - Argentina 20
CA - Canada 19
ES - Italia 15
NL - Olanda 15
ZA - Sudafrica 15
IQ - Iraq 13
EC - Ecuador 11
PL - Polonia 9
CL - Cile 7
CO - Colombia 7
PK - Pakistan 7
VE - Venezuela 7
CH - Svizzera 6
PE - Perù 6
SA - Arabia Saudita 6
CZ - Repubblica Ceca 5
ID - Indonesia 5
NO - Norvegia 5
AZ - Azerbaigian 4
BE - Belgio 4
BO - Bolivia 4
EG - Egitto 4
MA - Marocco 4
NP - Nepal 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
ET - Etiopia 3
IL - Israele 3
PT - Portogallo 3
PY - Paraguay 3
AM - Armenia 2
CY - Cipro 2
DK - Danimarca 2
EU - Europa 2
KE - Kenya 2
LV - Lettonia 2
NI - Nicaragua 2
PH - Filippine 2
RO - Romania 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MY - Malesia 1
PA - Panama 1
PS - Palestinian Territory 1
SN - Senegal 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 10.847
Città #
Moscow 1.445
Dublin 471
Singapore 455
Hong Kong 450
Santa Clara 382
San Jose 370
Seoul 171
Chandler 155
Ashburn 144
Ho Chi Minh City 112
Naples 102
Beijing 100
Hefei 99
Jacksonville 97
Aversa 81
Hanoi 65
Princeton 58
Roxbury 58
Istanbul 56
Bengaluru 49
Los Angeles 45
New York 44
Cambridge 43
The Dalles 30
Dallas 29
Caserta 28
Bremen 26
São Paulo 26
Munich 24
Da Nang 21
Orem 21
Milan 19
Wilmington 19
Des Moines 18
Afragola 17
Medford 17
Helsinki 14
Atlanta 13
Boardman 13
Frankfurt am Main 12
Johannesburg 12
Nuremberg 12
Rome 11
Falkenstein 10
San Francisco 10
Turku 10
Viterbo 10
Lappeenranta 9
Council Bluffs 8
Haiphong 8
Manchester 8
Rio de Janeiro 8
Tokyo 8
Vienna 8
Warsaw 8
Woodbridge 8
Baghdad 7
Brasília 7
Stockholm 7
Brooklyn 6
Chennai 6
Hải Dương 6
Mexico City 6
Norwalk 6
Belo Horizonte 5
Changsha 5
Chicago 5
Giugliano in Campania 5
Hamburg 5
Kyiv 5
London 5
Madrid 5
Manaus 5
Marzano di Nola 5
Pune 5
Ribeirão Preto 5
Tulsa 5
Bergen 4
Brussels 4
Bến Tre 4
Canoas 4
Etobicoke 4
Guarulhos 4
Guayaquil 4
Hillsboro 4
Jinan 4
Lima region 4
Nanjing 4
Nova Friburgo 4
Palo Alto 4
Porto Alegre 4
Quito 4
Redwood City 4
Sacramento 4
San Martino 4
San Mateo 4
Secaucus 4
Shanghai 4
Siano 4
Tashkent 4
Totale 5.755
Nome #
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa 177
A feasibility, acceptability and validation study of the Italian Version of a new cognitive remediation program for psychotic patients - CIRCuiTS 176
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 169
Aetiopathological mechanisms of negative symptoms in schizophrenia 167
Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature 162
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale 153
Assessment of the role of cognitive control on monetary reward and loss anticipation: An electrophysiological study in subjects with schizophrenia 151
'Precision psychiatry' needs to become part of 'personalized psychiatry' 151
Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features 149
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models 147
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study 146
Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex 144
Avolition and microstructural brain abnormalities in Schizophrenia: Reduced fractional anisotropy in pathways connecting amygdala and insular cortex 142
Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia 141
A multivariate approach to investigate the associations of electrophysiological indices with schizophrenia clinical and functional outcome 134
Electrophysiological Correlates of Reward Anticipation in Subjects with Schizophrenia: An ERP Microstate Study 134
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled study 133
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 132
Current limitations in technology-based cognitive assessment for severe mental illnesses: a focus on feasibility, reliability, and ecological validity 132
Autism Rating Scale: A New Tool for Characterizing the Schizophrenia Phenotype 131
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 130
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review 129
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature 129
External validation of the five domains of negative symptoms: Focus on cognition, functional capacity, and real-world functioning 127
The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia 127
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study 125
Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses 123
Accuracy of self-assessment of real-life functioning in schizophrenia 122
EPA guidance on assessment of negative symptoms in schizophrenia 121
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia 120
Clinical and psychological factors associated with resilience in patients with schizophrenia: data from the Italian network for research on psychoses using machine learning 120
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping 119
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review 119
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 117
Association of functional genetic variation in PP2A with prefrontal working memory processing 117
Negative Symptom Domains in Children and Adolescents at Ultra-High Risk for Psychosis: Association with Real-Life Functioning 116
EPA guidance on treatment of negative symptoms in schizophrenia 116
The relationship between the resting state functional connectivity and social cognition in schizophrenia: Results from the Italian Network for Research on Psychoses 115
Auditory P300 and cognition in schizophrenia: findings from a multicentre study 115
Sex and gender differences in clinical and functional indices in subjects with schizophrenia and healthy controls: Data from the baseline and 4-year follow-up studies of the Italian Network for Research on Psychoses 114
Functional connectivity of the ventral tegmental area and avolition in schizophrenia: A resting state functional MRI study 114
Neurobiology of Schizophrenia: Electrophysiological indices 113
Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review 112
Safety of electroconvulsive therapy (ECT) in pregnancy: a systematic review of case reports and case series 111
Resting-State Brain Activity Dysfunctions in Schizophrenia and Their Associations with Negative Symptom Domains: An fMRI Study 110
Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review 109
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 108
Illness-related variables and abnormalities of resting-state brain activity in schizophrenia 106
VTA-insula connectivity and avolition in subjects with schizophrenia 106
Unveiling the Associations between EEG Indices and Cognitive Deficits in Schizophrenia-Spectrum Disorders: A Systematic Review 105
ELECTROPHYSIOLOGICAL CORRELATES OF AVOLITION-APATHY DOMAIN IN SCHIZOPHRENIA 105
DISORGANIZATION AND COGNITIVE DYSFUNCTIONS IN SCHIZOPHRENIA: A STUDY OF RESTING STATE EEG 105
Neuroimaging: Diagnostic boundaries and biomarkers 104
Resting state functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia 103
Investigating the relationships of p3b with negative symptoms and neurocognition in subjects with chronic schizophrenia 102
Current goals of neuroimaging for mental disorders: a report by the WPA Section on Neuroimaging in Psychiatry 101
Factors Associated with Real-Life Functioning in Persons with Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 100
Depression and neurocognitive impairment: evaluation of their role as predictors of auditory N100 in schizophrenia 99
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning 98
Impact of Reward and Loss Anticipation on Cognitive Control: An Event-Related Potential Study in Subjects With Schizophrenia and Healthy Controls 98
Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study 98
Corrigendum: Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques (Front. Neurosci., (2020), 14, (632), 10.3389/fnins.2020.00632) 98
EPA guidance on assessment of cognitive impairment in schizophrenia 97
Social Cognition Impairments in 22q11.2DS Individuals With and Without Psychosis: A Comparison Study With a Large Population of Patients With Schizophrenia 97
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses 96
The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia 96
Functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia: a resting state functional MRI study 96
Disorganization and cognitive impairment in schizophrenia: New insights from electrophysiological findings 95
Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophrenia 95
Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia 95
Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial 94
Relationship between MMN and real-life functioning in subjects with schizophrenia 93
Effects of chronic antipsychotic treatment on neurophysiological correlates of the auditory oddball task in schizophrenia: A preliminary report from a multicentre study 92
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 92
MMN impairment in subjects with schizophrenia among different stages of disease 89
Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG 89
Electrophysiological and neurocognitive correlates of the disorganization factor in schizophrenia 88
Electrophysiological correlates of negative symptom domains in schizophrenia 88
Inter-rater reliability and psychometric characteristics of the Italian version of the Cognitive Assessment Interview (CAI) 88
White matter structural connectivity abnormalities in subjects with deficit schizophrenia: A diffusion tensor imaging study 86
Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study 86
We are not ready to abandon the current schizophrenia construct, but should be prepared to do so 85
EPA Guidance on treatment of cognitive impairment in schizophrenia 84
Prevalence of mental disorders and related risk factors in refugees and asylum seekers in Campania 83
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 83
The dimensional structure of the Positive and Negative Syndrome Scale in first-episode schizophrenia spectrum disorders: an Exploratory Graph Analysis from the OPTiMiSE trial 82
Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study 82
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses 82
The efficacy, feasibility and acceptability of a remotely accessible use of circuits, a computerized cognitive remediation therapy program for schizophrenia: A pilot study 82
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 82
Laryngopharyngeal reflux and psychological distress: a vicious cycle worth investigating 82
P3a and real-life functioning in a sample of chronic schizophrenia subjects 81
Neglected Vulnerabilities in Mental Health: Where Do We Need to Do More? 80
Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia 77
Social cognition and real-life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls 77
Understanding the Pathophysiology of Mental Diseases and Early Diagnosis Thanks to Electrophysiological Tools: Some Insights and Empirical Facts 74
Worldwide initiatives aimed to train professionals in the use of the ICD-11 74
Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study 74
The Brief negative Symptom Scale (BNSS): a systematic review of measurement properties 73
European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study 72
Totale 10.958
Categoria #
all - tutte 35.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 0 0 0 0 0 0 0 6 37 10
2021/2022420 5 1 9 12 106 16 14 8 17 71 38 123
2022/2023791 72 23 25 40 66 53 10 28 417 10 19 28
2023/2024468 25 24 37 39 134 46 9 10 7 9 32 96
2024/20251.899 7 19 11 142 263 265 260 147 256 263 136 130
2025/20267.022 343 485 331 302 609 3.749 446 304 241 212 0 0
Totale 11.119